PricewaterhouseCoopers (PwC) expects that healthcare mergers & acquisition activity will continue to trend in 2015.

Valeant Pharmaceuticals was competing against Endo Pharmaceuticals for the acquisition of Salix Pharmaceuticals.

In an effort to increase its oncology drugs division, AbbVie plans to purchase Pharmacyclics (the maker of the cancer drug, Imbruvica) for $21 billion.

This year is going to be filled with healthcare acquisitions as health systems, information technology, software firms, medical practices and service providers look to integrate due to the Affordable Care Act.

Emory University and WellStar Health System (both nonprofits) announced that they are contemplating a merger of their medical assets.